fda approves first oral glp-1 obesity drug august 21 2025 Orforglipron, approved as Foundayo on April 1, 2026, adds another option for chronic weight management in adults with or overweight plus at least one weight-related condition. The clinical relevance GLP-1 brands: Eli Lilly is

Older adults (there is reduced stomach acid production with age, and acid in the stomach is necessary to absorb vitamin B12)

The knee extension testwhere you try to straighten your leg against resistanceis commonly used

How much time do they have between malpractice insurance, between medical school bills that they're in debt with, between the overhead that they have run their practice

This offers a compelling mechanistic rationale for their use in DR, suggesting they do not merely offer a generic anti-inflammatory benefit, but may directly intervene in the specific immunological events now known to perpetuate retinal damage

What dose of MOTS-c do people use for results